Stock listing
Mineralys Therapeutics, Inc.
Selected listing: MLYS · NASDAQ · USD · US
Mineralys Therapeutics, Inc. (NASDAQ:MLYS), Health Technology. Latest release Oct 2, 2026: Mineralys Therapeutics Announces Presentation of New Lorundrostat…
- Ticker
- NASDAQ:MLYS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. is a public company traded under the ticker MLYS in the American market. Mineralys focuses on developing innovative therapies to address unmet medical needs.
Latest news from Mineralys Therapeutics, Inc.
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
October 2, 2026
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
October 1, 2026
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
October 1, 2026
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
September 30, 2026
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 28, 2026
Events
Research Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. company profile
View the public company page for Mineralys Therapeutics, Inc. on 6ix.
Mineralys Therapeutics, Inc. news
Read company news and market updates connected to Mineralys Therapeutics, Inc..
Mineralys Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Mineralys Therapeutics, Inc..